BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37884161)

  • 1. GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer's disease mouse model.
    Park H; Kwon HS; Lee KY; Kim YE; Son JW; Choi NY; Lee EJ; Han MH; Park DW; Kim S; Koh SH
    Brain Behav Immun; 2024 Jan; 115():295-307. PubMed ID: 37884161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.
    Park HH; Kwon HS; Lee KY; Kim YE; Son JW; Choi NY; Han MH; Park DW; Kim S; Koh SH
    Aging (Albany NY); 2024 Jan; 16(3):1983-2004. PubMed ID: 38301041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Duncan MJ; Guerriero LE; Kohler K; Beechem LE; Gillis BD; Salisbury F; Wessel C; Wang J; Sunderam S; Bachstetter AD; O'Hara BF; Murphy MP
    Neuroscience; 2022 Jan; 481():111-122. PubMed ID: 34856352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
    Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
    J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
    Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
    J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
    J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
    Neddens J; Daurer M; Flunkert S; Beutl K; Loeffler T; Walker L; Attems J; Hutter-Paier B
    PLoS One; 2020; 15(7):e0235543. PubMed ID: 32645028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
    Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
    J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.